Subscription for Warrants. In accordance with the terms of the Offering, the Warrants have been subscribed for by, and shall be issued to, the Investors immediately following the execution of the Warrant Instrument. The Warrants will be issued in certificated form in the form set out in Appendix (C) (each such certificate, a “Warrant Certificate”). The Company or its duly authorized agent shall maintain a register of the holders of Warrants, the Warrant Certificates they hold, and the number of Warrant Shares (defined below) for which their Warrants are exercisable. The Company shall be entitled to treat each person named in the register of the holders of Warrants as a Warrantholder as the absolute owner of a Warrant and, accordingly, shall not, except as ordered by a court of competent jurisdiction or as required by law, be bound to recognise any equitable or other claim to or interest in a Warrant on the part of any other person, whether or not it shall have express or other notice of such a claim. The Warrants will not be listed by the Company on a regulated market or other trading platform.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Mereo Biopharma Group PLC), Warrant Instrument (Mereo Biopharma Group PLC)